NYSE:HYH - Halyard Health Stock Price, Price Target & More

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

Halyard Health (NYSE:HYH) released its quarterly earnings data on Wednesday, May, 2nd. The medical instruments supplier reported $0.76 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.59. The medical instruments supplier had revenue of $156.40 million for the quarter, compared to analysts' expectations of $155.08 million. Halyard Health had a return on equity of 7.90% and a net margin of 7.72%. The firm's quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.48 earnings per share. View Halyard Health's Earnings History.

Halyard Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share (EPS) guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.26.

5 brokerages have issued 12 month price targets for Halyard Health's shares. Their predictions range from $50.00 to $62.00. On average, they expect Halyard Health's stock price to reach $55.50 in the next twelve months. View Analyst Ratings for Halyard Health.

Some companies that are related to Halyard Health include William Demant (WILYY), STERIS (STE), Inogen (INGN), Mine Safety Appliances (MSA), Wright Medical Group (WMGI), Consort Medical (CSRMY), Invacare (IVC), Sientra (SIEN), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), BioCardia (BCDA), Histogenics (HSGX), ReWalk Robotics (RWLK) and NanoVibronix (NAOV).

News articles about HYH stock have trended somewhat positive this week, Accern reports. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Halyard Health earned a daily sentiment score of 0.08 on Accern's scale. They also assigned media coverage about the medical instruments supplier an impact score of 47.92 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Halyard Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.62%), Dimensional Fund Advisors LP (7.28%), Paradice Investment Management LLC (3.30%), Northern Trust Corp (3.23%), Champlain Investment Partners LLC (1.60%) and Prudential Financial Inc. (1.03%). View Institutional Ownership Trends for Halyard Health.

HYH stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Prudential Financial Inc., Chicago Equity Partners LLC, Schwab Charles Investment Management Inc., Wells Fargo & Company MN, Spark Investment Management LLC, Citigroup Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for Halyard Health.

HYH stock was bought by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Select Equity Group L.P., Great West Life Assurance Co. Can, New York State Common Retirement Fund, Lord Abbett & CO. LLC, Millennium Management LLC, BlackRock Inc. and Great Lakes Advisors LLC. View Insider Buying and Selling for Halyard Health.

Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of HYH stock can currently be purchased for approximately $53.47.

Halyard Health has a market capitalization of $2.51 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe.

Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]